Edarbi Oral Tablet 40Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Edarbi: Oral tablet (40mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_16960.JPG
Edarbi 40mg Tablet
Arbor Pharmaceuticals, LLC
Pill Identification: ASL  |  40

What is this Medicine?

AZILSARTAN (AY zil SAR tan) is used to treat high blood pressure.

CVS Pharmacy Patient Statistics for Edarbi: Oral tablet(40mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Edarbi 40mg Tablet

NDC: 647640844
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Hypertension

Storage Information
Protect from light
Store in original container
Protect from moisture
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Edarbi 40mg Tablet
Drug Image file DrugItem_16960.JPG
Arbor Pharmaceuticals, LLC
Pill Identification: ASL  |  40
Shape: round
Color: white

Reported Side Effects for Edarbi 40mg Tablet

Anemia Incidence:
<0.4%*
Severity: MODERATE
Onset: DELAYED
Loose Stools Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
>0.3%*
Severity: MILD
Onset: EARLY
Weakness Incidence:
>0.3%*
Severity: MILD
Onset: DELAYED
Muscle Cramps Incidence:
>0.3%*
Severity: MILD
Onset: DELAYED
Cough Incidence:
>0.3%*
Severity: MILD
Onset: DELAYED
Tired Incidence:
1.1-2.5%*
Severity: MILD
Onset: EARLY
Lightheadedness Incidence:
2.1-3.6%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

SECOND Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

THIRD Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Edarbi

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.